Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease-Reference-Cited by-同舟云学术

Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease

Published:2018 Issue: Volume: Page:549-571
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Bagher Amina M.,Laprairie Robert B.,Kelly Melanie E. M.,Denovan-Wright Eileen M.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7825-0_25

Reference66 articles.

1. Labbadia J, Morimoto RI (2013) Huntington’s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38:378–385

2. Ross CA, Aylward EH, Wild EJ et al (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204–216

3. Bachoud-Levi AC, Deglon N, Nguyen JP et al (2000) Neuroprotective gene therapy for Huntington’s disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther 11:1723–1729

4. Bloch J, Bachoud-Levi AC, Deglon N et al (2004) Neuroprotective gene therapy for Huntington’s disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 15:968–975

5. Ramaswamy S, Kordower JH (2012) Gene therapy for Huntington’s disease. Neurobiol Dis 48:243–254

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice;Saudi Pharmaceutical Journal;2023-02

2. Degeneration of retina-brain components and connections in glaucoma: Disease causation and treatment options for eyesight preservation;Current Research in Neurobiology;2022

3. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?;Pharmacology Biochemistry and Behavior;2021-07

4. Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature;Journal of Neuroscience and Neurological Disorders;2021-06-03

5. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases;Cannabinoids and Neuropsychiatric Disorders;2020-12-18